Precigen Announces Proposed $30 Million Public Offering of Common Stock

GERMANTOWN, Md. , Aug. 6, 2024 /PRNewswire/ -- Precigen, Inc.

(Nasdaq: PGEN ) today announced it has commenced a $30.0 million underwritten public offering of its common stock. In addition, Precigen intends to grant the underwriters a 30-day option to purchase up to an additional $4.

5 million of common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the size or terms of the offering. All of the shares in the proposed offering are to be sold by Precigen.

Stifel is acting as the sole book-running manager for the offering. The public offering will be made pursuant to a shelf registration statement on Form S-3 that was previously filed with the Securities and Exchange Commission (SEC) and became effective on January 17, 2024 . A preliminary prospectus supplement and accompanying base prospectus relating to and describing the terms of the offering will be filed with the SEC and will be on the SEC's website at www.

sec.gov . Copies of the preliminary prospectus supplement and base prospectus relating to this offering may be obtained, when available, from Stifel, Nicolaus & Company, Incorporated, Attention: Prospectus Department, One Montgomery Street , Suite 3700, San Francisco, CA 94104, by telephone at +1 (415) 364-2720 or by email at [email protected] .

The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC. This press rel.